Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$612.05
$602.77
$373.00
▼
$677.90
$17.08B1.18262,874 shs159,763 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,551.26
+0.1%
$1,424.82
$1,023.05
▼
$1,585.72
$31.09B1.19226,222 shs180,642 shs
Qiagen N.V. stock logo
QGEN
Qiagen
$45.42
+0.1%
$43.47
$32.53
▼
$57.81
$9.36B0.612.31 million shs1.26 million shs
Revvity Inc. stock logo
RVTY
Revvity
$154.20
+0.0%
$132.48
$81.22
▼
$166.25
$17.21B1.062.36 million shs1.22 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+2.10%+4.18%+15.44%+22.11%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.00%+4.26%+19.89%+19.38%+21.73%
Qiagen N.V. stock logo
QGEN
Qiagen
0.00%+1.53%+7.15%+9.60%-8.05%
Revvity Inc. stock logo
RVTY
Revvity
0.00%+1.81%+23.89%+39.01%+74.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$612.05
$602.77
$373.00
▼
$677.90
$17.08B1.18262,874 shs159,763 shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,551.26
+0.1%
$1,424.82
$1,023.05
▼
$1,585.72
$31.09B1.19226,222 shs180,642 shs
Qiagen N.V. stock logo
QGEN
Qiagen
$45.42
+0.1%
$43.47
$32.53
▼
$57.81
$9.36B0.612.31 million shs1.26 million shs
Revvity Inc. stock logo
RVTY
Revvity
$154.20
+0.0%
$132.48
$81.22
▼
$166.25
$17.21B1.062.36 million shs1.22 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+2.10%+4.18%+15.44%+22.11%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.00%+4.26%+19.89%+19.38%+21.73%
Qiagen N.V. stock logo
QGEN
Qiagen
0.00%+1.53%+7.15%+9.60%-8.05%
Revvity Inc. stock logo
RVTY
Revvity
0.00%+1.81%+23.89%+39.01%+74.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$607.73-0.71% Downside
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
2.27
Hold$1,459.54-5.91% Downside
Qiagen N.V. stock logo
QGEN
Qiagen
2.43
Hold$43.51-4.22% Downside
Revvity Inc. stock logo
RVTY
Revvity
2.26
Hold$120.50-21.86% Downside

Current Analyst Ratings Breakdown

Latest QGEN, MTD, RVTY, and MEDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UpgradeBuy (B-) ➝ Buy (B)
10/8/2026
Revvity Inc. stock logo
RVTY
Revvity
UpgradeHold (C-) ➝ Hold (C)
10/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetOutperform$665.00 ➝ $700.00
10/7/2026
Revvity Inc. stock logo
RVTY
Revvity
Boost Price TargetEqual Weight$115.00 ➝ $160.00
10/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetEqual Weight$600.00 ➝ $625.00
10/7/2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Boost Price TargetOverweight$1,575.00 ➝ $1,700.00
10/5/2026
Revvity Inc. stock logo
RVTY
Revvity
Initiated CoverageOutperform
9/30/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Initiated CoverageSell ➝ Neutral$405.00 ➝ $673.00
9/30/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UpgradeSell ➝ Hold$405.00 ➝ $673.00
9/14/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Reiterated RatingHold
9/11/2026
Qiagen N.V. stock logo
QGEN
Qiagen
UpgradeHold (C-) ➝ Hold (C)
(Data available from 10/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.78B6.14$17.02 per share35.97$16.30 per share37.55
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$4.03B7.72$49.67 per share31.23($1.16) per share-1,337.29
Qiagen N.V. stock logo
QGEN
Qiagen
$2.09B4.48$3.41 per share13.33$17.89 per share2.54
Revvity Inc. stock logo
RVTY
Revvity
$2.86B6.02$8.82 per share17.49$63.95 per share2.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0635.8831.932.7317.67%110.15%24.84%10/21/2026 (Confirmed)
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$869.19M$44.4334.9129.683.1021.91%-1,212.14%25.11%11/5/2026 (Estimated)
Qiagen N.V. stock logo
QGEN
Qiagen
$424.88M$1.9523.2717.404.5219.49%14.47%8.34%11/3/2026 (Estimated)
Revvity Inc. stock logo
RVTY
Revvity
$241.20M$2.1073.4326.142.808.16%8.34%5.01%11/3/2026 (Confirmed)

Latest QGEN, MTD, RVTY, and MEDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$12.12N/AN/AN/A$1.07 billionN/A
11/3/2026Q3 2026
Qiagen N.V. stock logo
QGEN
Qiagen
$0.6210N/AN/AN/A$535.62 millionN/A
11/3/2026Q3 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.30N/AN/AN/A$694.74 millionN/A
10/21/2026Q3 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$4.44N/AN/AN/A$714.47 millionN/A
8/5/2026Q2 2026
Qiagen N.V. stock logo
QGEN
Qiagen
$0.5980$0.62+$0.0220$0.50$527.50 million$535.04 million
8/4/2026Q2 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.21$1.41+$0.20$0.47$702.96 million$729.69 million
7/31/2026Q2 2026
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$10.78$11.46+$0.68$11.55$1.03 billion$1.03 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
Qiagen N.V. stock logo
QGEN
Qiagen
$0.350.77%N/A17.95%N/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.18%N/A13.33%N/A

Latest QGEN, MTD, RVTY, and MEDP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2026
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.25%10/23/202610/23/202611/13/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
159.45
1.12
0.78
Qiagen N.V. stock logo
QGEN
Qiagen
0.48
2.85
2.31
Revvity Inc. stock logo
RVTY
Revvity
0.36
1.80
1.50

Institutional Ownership

CompanyInstitutional Ownership
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
95.07%
Qiagen N.V. stock logo
QGEN
Qiagen
70.00%
Revvity Inc. stock logo
RVTY
Revvity
86.65%

Insider Ownership

CompanyInsider Ownership
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.71%
Qiagen N.V. stock logo
QGEN
Qiagen
9.00%
Revvity Inc. stock logo
RVTY
Revvity
0.85%
CompanyEmployeesShares OutstandingFree FloatOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
18,10020.04 million19.90 millionOptionable
Qiagen N.V. stock logo
QGEN
Qiagen
5,654206.07 million187.53 millionOptionable
Revvity Inc. stock logo
RVTY
Revvity
11,000111.59 million110.64 millionOptionable

Recent News About These Companies

What Does Revvity (NYSE:RVTY) New Assay Add to NYSE Composite?
Revvity earnings preview: What to expect
Revvity to Host Investor Day
Revvity (NYSE:RVTY) CAO Sells $13,060.32 in Stock
Revvity Goes Higher on Q3 Figures
Revvity to Hold Earnings Call on November 3, 2026
Revvity (NYSE:RVTY) Sets New 52-Week High - Here's Why
Revvity stock gains 5.2 percent ahead of the open
Revvity (NYSE:RVTY) Shares Up 5.2% - Time to Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Medpace stock logo

Medpace NASDAQ:MEDP

$612.05 0.00 (0.00%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$611.57 -0.48 (-0.08%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Mettler-Toledo International stock logo

Mettler-Toledo International NYSE:MTD

$1,551.26 +1.27 (+0.08%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$1,550.01 -1.25 (-0.08%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Qiagen stock logo

Qiagen NYSE:QGEN

$45.42 +0.04 (+0.09%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$45.40 -0.03 (-0.06%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Revvity stock logo

Revvity NYSE:RVTY

$154.20 +0.02 (+0.01%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$154.83 +0.63 (+0.41%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.